<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50256</article-id><article-id pub-id-type="doi">10.7554/eLife.50256</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-150743"><name><surname>Ng</surname><given-names>Kevin W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1635-6768</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150739"><name><surname>Attig</surname><given-names>Jan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2159-2880</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150740"><name><surname>Young</surname><given-names>George R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163652"><name><surname>Ottina</surname><given-names>Eleonora</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150744"><name><surname>Papamichos</surname><given-names>Spyros I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7119-0647</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150742"><name><surname>Kotsianidis</surname><given-names>Ioannis</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-149803"><name><surname>Kassiotis</surname><given-names>George</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8457-2633</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Retroviral Immunology</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Retrovirus-Host Interactions</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Haematology</institution>, <institution>Democritus University of Thrace Medical School</institution>, <addr-line><named-content content-type="city">Alexandroupolis</named-content></addr-line>, <country>Greece</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-4550"><name><surname>Chang</surname><given-names>Howard Y</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>george.kassiotis@crick.ac.uk</email> (GK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>11</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e50256</elocation-id><history><date date-type="received"><day>16</day><month>07</month><year>2019</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Ng et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ng et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50256-v1.pdf"/><abstract><p>Immune regulation is a finely balanced process of positive and negative signals. PD-L1 and its receptor PD-1 are critical regulators of autoimmune, anti-viral and anti-tumoural T cell responses. Although the function of its predominant membrane-bound form is well-established, the source and biological activity of soluble PD-L1 (sPD-L1) remain incompletely understood. Here, we show that sPD-L1 in human healthy tissues and tumours is produced by exaptation of an intronic <italic>LINE-2A</italic> (<italic>L2A</italic>) endogenous retroelement in the <italic>CD274</italic> gene, encoding PD-L1, which causes omission of the transmembrane domain and the regulatory sequence in the canonical 3' untranslated region. The alternatively spliced <italic>CD274-L2A</italic> transcript forms the major source of sPD-L1 and is highly conserved in hominids, but lost in mice and a few related species. Importantly, <italic>CD274-L2A</italic>-encoded sPD-L1 lacks measurable T cell inhibitory activity. Instead, it functions as a receptor antagonist, blocking the inhibitory activity of PD-L1 bound on cellular or exosomal membranes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010438</institution-id><institution>Francis Crick Institute</institution></institution-wrap></funding-source><award-id>10099</award-id><principal-award-recipient><name><surname>Ng</surname><given-names>Kevin W</given-names></name><name><surname>Attig</surname><given-names>Jan</given-names></name><name><surname>Young</surname><given-names>George R</given-names></name><name><surname>Ottina</surname><given-names>Eleonora</given-names></name><name><surname>Kassiotis</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>102898/B/13/Z</award-id><principal-award-recipient><name><surname>Kassiotis</surname><given-names>George</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the ethical committee of the Francis Crick Institute and conducted according to local guidelines and UK Home Office regulations under the Animals Scientific Procedures Act 1986 (ASPA) (licence number: PCD77C6D0)</p></fn><fn fn-type="other"><p>Human subjects: This study was reviewed and approved by The Francis Crick Institute's Human Ethics Group and all experiments were carried out in accordance with the United Kingdom's Human Tissue Act (2004). All participants provided written informed consent prior to participation in the study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1G, Figure 1-figure supplement 3, and Figure 3B.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Linsley et al</collab></person-group><year iso-8601-date="2014">2014</year><source>Next generation sequencing of human immune cell subsets across diseases</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJNA258216">https://www.ebi.ac.uk/ena/data/view/PRJNA258216</ext-link><comment>European Nucleotide Archive, SRP045500</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>The Cancer Genome Atlas</collab></person-group><year iso-8601-date="2017">2017</year><source>The Cancer Genome Atlas</source><ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link><comment>TCGA</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>The Genotype-Tissue Expression</collab></person-group><year iso-8601-date="2017">2017</year><source>The Genotype-Tissue Expression</source><ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/datasets">https://gtexportal.org/home/datasets</ext-link><comment>GTEx</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Broad Institute Cancer Cell Line Encyclopedia</collab></person-group><year iso-8601-date="2017">2017</year><source>Broad Institute Cancer Cell Line Encyclopedia</source><ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/ccle">https://portals.broadinstitute.org/ccle</ext-link><comment>CCLE</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-50256-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>